'Viewpoint' addresses IOM report on genome-based therapeutics and companion diagnostics
The promise of personalized medicine, says University of Vermont (UVM) molecular pathologist Debra Leonard, M.D., Ph.D., is the ability to tailor therapy based on markers in the patient's genome and, in the case of cancer, ...
Feb 12, 2014
0
0